Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BY 4.0Advanced Science

Hypoxic Preconditioning Restores NK Cell Metabolic Fitness by Attenuating MAPK Signaling to Potentiate Antitumor Immunity in Lung Cancer

1 more authors
6 affiliations
  1. 1School of Biomedical Engineering Guangzhou Medical University Guangzhou Guangdong China
  2. 2Guangzhou National Laboratory Guangzhou Guangdong China
  3. 3College of Life Science and Technology Huazhong University of Science and Technology Wuhan Hubei China
  4. 4Institute of Cytology and Genetics School of Basic Medical Sciences Hengyang Medical School University of South China Hengyang Hunan China
  5. 5School of Forestry and Biotechnology Zhejiang A&F University Hangzhou China
  6. 6National Key Laboratory for Development and Utilization of Forest Food Resources Zhejiang A&F University Hangzhou China

Abstract

Solid tumor hypoxia is a major barrier to NK cell‐based immunotherapy. To address this challenge, we establish a hypoxic preconditioning (HPC) model. We find that acute hypoxia (AH; 1% O2) significantly impairs NK92 cell cytotoxicity—such as granzyme B secretion and infiltration into lung cancer cell spheroids. In contrast, HPC pretreatment (gradual reduction from 5% to 1% O2) remarkably restores these functions. Mechanistically, transcriptomic analysis reveals that HPC markedly attenuates hypoxia ‐induced aberrant MAPK pathway activation. MAPK attenuation under normoxia recapitulates HPC ‐like protection by promoting mitochondrial biogenesis and metabolic remodeling, thereby enhancing the antitumor activity of NK92 cells both in vitro and in vivo. Notably, systemic MAPK inhibitor injection increases NKp46 expression on endogenous NK cells in BALB/c mice. Importantly, this strategy is also effective in human induced pluripotent stem cell (hiPSC)‐derived induced NK (iNK) cells, supporting broader evaluation across NK cell platforms. Collectively, this study identifies the MAPK–mitochondrial metabolic axis as a critical regulator of hypoxia‐induced NK cell dysfunction and proposes metabolic preconditioning as a strategy to overcome solid tumor hypoxia.

Related

  1. A signaling-optimized TIGIT chimeric switch receptor promotes metabolic fitness and antitumor efficacy of TCR/CAR T cells
    E. Antunes Ferreira, K. J. Legscha, U. R. Schmits +3
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. Hopeaphenol targets histidine kinase signaling across kingdoms to suppress bacterial virulence and potentiate plant immunity
    J. Kang, N. Yoo, T. Karasov +4
    bioRxivPreprintCC BY-NC-NDFull textPlant biologybioRxiv
  3. Combined Probiotics and Phenolics in Western Diet-fed Rats Enhance Parasympathetic Tone in the Gut–Brain Axis by Attenuating Inflammasome Signaling, and Reshaping Gut Microbiome
    José Patrocínio Ribeiro Cruz Neto, Murielle Godet, Paulo César Trindade da Costa +9
    Probiotics and Antimicrobial ProteinsPeer-reviewedCC BY 4.0Full textGeneral biologyNutritionHAL
  4. 713 Vitamin B6-mediated lipid metabolic reprogramming as a strategy to restore antitumor T cell immunity in aging
    Nicola Vannini, Helen Carrasco Hope, Claudia Cifuentes Caballero +2
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  5. A living enzymatic adenosine switch couples metabolic rescue to IL-12-driven antitumor immunity
    Rizwan Romee, Stephanie Sendker, Shaobo Yang +30
    Research SquarePreprintCC BY 4.0Full textSystems & synthetic biologyPMC
BibTeX
@article{zhuang2026hypoxic,
  title = {{Hypoxic Preconditioning Restores NK Cell Metabolic Fitness by Attenuating MAPK Signaling to Potentiate Antitumor Immunity in Lung Cancer}},
  author = {Dian Zhuang and Xiaoyue Zhu and Na Wang and Qianqian Liu and Lihua Chen and Yanzhuo Ye and Lingrui Shang and Shasha Huang and Cong Ma and Wei Kevin Zhang and Tao Xu and Jiaqi Sun and Huisheng Liu},
  journal = {Advanced Science},
  year = {2026},
  month = nov,
  doi = {10.1002/advs.78759},
  url = {https://doi.org/10.1002/advs.78759},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Hypoxic Preconditioning Restores NK Cell Metabolic Fitness by Attenuating MAPK Signaling to Potentiate Antitumor Immunity in Lung Cancer
AU  - Dian Zhuang
AU  - Xiaoyue Zhu
AU  - Na Wang
AU  - Qianqian Liu
AU  - Lihua Chen
AU  - Yanzhuo Ye
AU  - Lingrui Shang
AU  - Shasha Huang
AU  - Cong Ma
AU  - Wei Kevin Zhang
AU  - Tao Xu
AU  - Jiaqi Sun
AU  - Huisheng Liu
PY  - 2026
DA  - 2026/11/09
JO  - Advanced Science
DO  - 10.1002/advs.78759
UR  - https://doi.org/10.1002/advs.78759
AB  - Solid tumor hypoxia is a major barrier to NK cell‐based immunotherapy. To address this challenge, we establish a hypoxic preconditioning (HPC) model. We find that acute hypoxia (AH; 1% O2) significantly impairs NK92 cell cytotoxicity—such as granzyme B secretion and infiltration into lung cancer cell spheroids. In contrast, HPC pretreatment (gradual reduction from 5% to 1% O2) remarkably restores these functions. Mechanistically, transcriptomic analysis reveals that HPC markedly attenuates hypoxia ‐induced aberrant MAPK pathway activation. MAPK attenuation under normoxia recapitulates HPC ‐like protection by promoting mitochondrial biogenesis and metabolic remodeling, thereby enhancing the antitumor activity of NK92 cells both in vitro and in vivo. Notably, systemic MAPK inhibitor injection increases NKp46 expression on endogenous NK cells in BALB/c mice. Importantly, this strategy is also effective in human induced pluripotent stem cell (hiPSC)‐derived induced NK (iNK) cells, supporting broader evaluation across NK cell platforms. Collectively, this study identifies the MAPK–mitochondrial metabolic axis as a critical regulator of hypoxia‐induced NK cell dysfunction and proposes metabolic preconditioning as a strategy to overcome solid tumor hypoxia.
SN  - 2198-3844
ER  -